メニュー
JP | JPY
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
JP | JPY
Sorry, we couldn't find anything on our website containing your search term.

2020 Eppendorf Award for Young European Investigators Goes to Randall Platt
news
- プレスリリース
Prize Ceremony Postponed to 2021 in Response to COVID-19 Outbreak
Prize Ceremony Postponed to 2021 in Response to COVID-19 Outbreak
Hamburg, March 31, 2020
In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 25th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators.
Randall Platt, born 1987, receives the € 20,000 prize for his pioneering work developing a method to record timelines of gene expression events using a CRISPR-Cas system.
The Jury: “This system works by small pieces of RNA being inserted into the genome of a non-pathogenic bacterium in response to environmental changes. This system enables progress toward future development of a gut microbiome (normal intestinal flora) that can report experiences of the host organism and shows potential for use as a diagnostic tool to predict individualized precision interventions for both humans and other animals.”
Randall Platt: “Receiving the Eppendorf Award is a tremendous honor, one in which I share with my laboratory, collaborators, and family. My research focuses on developing innovative technologies that empower scientists to ask fundamental questions and develop therapeutics and diagnostics. The Award specifically recognizes my laboratory’s work on living diagnostics – engineered bacteria that act as biographers of their environment by continuously recording gene expression information – which may in the future provide a non-invasive tool to diagnose and individualize therapies for patients around the world.”
In response to the rapidly changing situation of the Corona virus outbreak (COVID-19), the Award ceremony at the EMBL Advanced Training Centre in Heidelberg, which was planned for June 25, 2020, within the Young European Investigators Conference, has been rescheduled to June 24, 2021.
More information about entry details, judging procedures, and past winners can be found at www.eppendorf.com/award
More information about the Young European Investigators Conference 2021 can be found at www.eppendorf.com/award/25years
With the Eppendorf Award for Young European Investigators, which was established in 1995, Eppendorf AG honors outstanding work in biomedical research and supports young scientists in Europe up to the age of 35. The Eppendorf Award is presented in partnership with the scientific journal Nature. The Award winner is selected by an independent committee composed of Prof. Reinhard Jahn (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany), Prof. Maria Leptin (EMBO, Heidelberg, Germany), Prof. Martin J. Lohse (Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany), and Prof. Laura Machesky (Cancer Research UK Beatson Institute, Glasgow, UK).
Hamburg, March 31, 2020
In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 25th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators.
Randall Platt, born 1987, receives the € 20,000 prize for his pioneering work developing a method to record timelines of gene expression events using a CRISPR-Cas system.
The Jury: “This system works by small pieces of RNA being inserted into the genome of a non-pathogenic bacterium in response to environmental changes. This system enables progress toward future development of a gut microbiome (normal intestinal flora) that can report experiences of the host organism and shows potential for use as a diagnostic tool to predict individualized precision interventions for both humans and other animals.”
Randall Platt: “Receiving the Eppendorf Award is a tremendous honor, one in which I share with my laboratory, collaborators, and family. My research focuses on developing innovative technologies that empower scientists to ask fundamental questions and develop therapeutics and diagnostics. The Award specifically recognizes my laboratory’s work on living diagnostics – engineered bacteria that act as biographers of their environment by continuously recording gene expression information – which may in the future provide a non-invasive tool to diagnose and individualize therapies for patients around the world.”
In response to the rapidly changing situation of the Corona virus outbreak (COVID-19), the Award ceremony at the EMBL Advanced Training Centre in Heidelberg, which was planned for June 25, 2020, within the Young European Investigators Conference, has been rescheduled to June 24, 2021.
More information about entry details, judging procedures, and past winners can be found at www.eppendorf.com/award
More information about the Young European Investigators Conference 2021 can be found at www.eppendorf.com/award/25years
With the Eppendorf Award for Young European Investigators, which was established in 1995, Eppendorf AG honors outstanding work in biomedical research and supports young scientists in Europe up to the age of 35. The Eppendorf Award is presented in partnership with the scientific journal Nature. The Award winner is selected by an independent committee composed of Prof. Reinhard Jahn (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany), Prof. Maria Leptin (EMBO, Heidelberg, Germany), Prof. Martin J. Lohse (Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany), and Prof. Laura Machesky (Cancer Research UK Beatson Institute, Glasgow, UK).
- Download the Eppendorf Press Release
もっと読む
表示を減らす